The amino acid residues found mutated in POLE occur in the exonuclease domain and initial characterization of the mutant enzymes showed that, like catalytic active site mutations, the cancer mutations impaired exonuclease proofreading activity, though to varying degrees (32,33). Here, POLE is linked to cancer.